Biosig ceo kenneth l. londoner to present at the 33rd annual virtual roth conference

Westport, ct, march 09, 2021 (globe newswire) -- biosig technologies, inc. (nasdaq: bsgm) ("biosig" or the "company"), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ecg and intra-cardiac signals, today announced that it will present at the 33rd annual virtual roth conference, being held on march 15-17, 2021. kenneth l. londoner, chairman, and ceo of biosig technologies, inc. will deliver a company overview and provide updates on recent progress. mr. londoner will also be available for investor meetings.
BSGM Ratings Summary
BSGM Quant Ranking